---
title: "Aidea Pharma: Sodium Dolutegravir API receives approval for listing application"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262866071.md"
description: "Aidea Pharma's wholly-owned subsidiary, Yangzhou Aidea Pharmaceutical Technology Co., Ltd., has received approval from the National Medical Products Administration to market the active pharmaceutical ingredient of Multilavir Sodium. This drug is used for the treatment of HIV infection and is suitable for adults and children over 12 years old. This approval will enhance the supply and quality of the active pharmaceutical ingredient, reduce production costs, and strengthen the company's competitiveness, but it is expected to have no significant impact on recent operations"
datetime: "2025-10-27T10:09:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262866071.md)
  - [en](https://longbridge.com/en/news/262866071.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262866071.md)
---

# Aidea Pharma: Sodium Dolutegravir API receives approval for listing application

Aidea Pharma announced that its wholly-owned subsidiary, Yangzhou Aidea Pharmaceutical Technology Co., Ltd., received the "Approval Notice for the Listing Application of Chemical Raw Materials" issued by the National Medical Products Administration on October 27, 2025. The name of the raw material drug is Dolutegravir Sodium, and the registration number is Y20240000542. This raw material drug is part of the company's fundraising project for the R&D of high-end generic drugs for HIV, specifically the sub-project ADC201 formulation, indicated for use in combination with other antiretroviral drugs for the treatment of adult and pediatric patients aged 12 years and older infected with the human immunodeficiency virus. This approval will further ensure the supply and quality of the raw material drug, reduce production costs, and enhance the company's core competitiveness. It is expected to have no significant impact on the company's recent operations

### Related Stocks

- [688488.CN](https://longbridge.com/en/quote/688488.CN.md)

## Related News & Research

- [El Niño Fears Push Coffee Prices Higher](https://longbridge.com/en/news/287248088.md)
- [Is RFK's 'carnivore diet' healthy? Here's what you need to know.](https://longbridge.com/en/news/286951172.md)
- [Is Gardening the Secret to Long-term Exercise?](https://longbridge.com/en/news/287245333.md)
- [Should You Be Adding Daewoong Pharmaceutical (KRX:069620) To Your Watchlist Today?](https://longbridge.com/en/news/286824214.md)
- [BYD is struggling to meet demand for new fast-charging EVs as orders reach 100K, 60K](https://longbridge.com/en/news/287109883.md)